Pfizer and Clear Creek Bio to collaborate on a research program targeting SARS-CoV-2 papain-like protease
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
Bayer supports rebuilding of Ukrainian healthcare system by donating 1.3 million euros
- Details
- Category: Bayer
![Bayer Bayer](/images/logo/bayer.png)
Eisai and Biogen announced the results from large global Phase 3 confirmatory Clarity AD clinical study of lecanemab
- Details
- Category: Business
![Eisai Eisai](/images/logo/eisai.png)
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/logo/astrazeneca.png)
Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
GSK announces positive Phase IIa study results for a new first-in-class candidate medicine for patients with tuberculosis
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/logo/gsk.png)
Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn® Beta approved by the European Commission
- Details
- Category: Sanofi
![Sanofi Sanofi](/images/logo/sanofi.png)
More Pharma News ...
- Pfizer and BioNTech receive positive CHMP opinion for Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster for children 5 through 11 years of age in European Union
- Vividion Therapeutics names Jenna Goldberg as Chief Medical Officer
- Bayer with continued strong performance
- Pfizer's elranatamab granted FDA Breakthrough Therapy Designation for relapsed or refractory multiple myeloma
- Salvat Laboratories announces submission of New Drug Application to the U.S. FDA for Clobetasol Nanoemulsion for treating inflammation and pain after ocular surgery
- Pfizer and BioNTech announce positive early data from clinical trial of Omicron BA.4/BA.5-adapted bivalent booster in individuals 18 years and older
- Bayer signs grant agreement to advance innovation in non-hormonal contraception